The activation of STAT3 is among the pathways proposed to be involved in the development of drug resistance in oncogene-addicted tumor cells, although the specific mechanism is still unclear: STAT3 could be activated to prevent apoptosis and sustain cell viability but it may also be activated early in a cancer-cell sub-population, maybe immediately after drug exposure [34]. This evidence concerns the gene STAT3 and neoplasm.